Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection.
Lee WS, Tan HX, Reynaldi A, Esterbauer R, Koutsakos M, Nguyen J, Amarasena T, Kent HE, Aggarwal A, Turville SG, Taiaroa G, Kinsella P, Liew KC, Tran T, Williamson DA, Cromer D, Davenport MP, Kent SJ, Juno JA, Khoury DS, Wheatley AK. Lee WS, et al. Among authors: amarasena t. Sci Adv. 2023 Jul 21;9(29):eadg5301. doi: 10.1126/sciadv.adg5301. Epub 2023 Jul 21. Sci Adv. 2023. PMID: 37478181 Free PMC article.
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.
Koutsakos M, Reynaldi A, Lee WS, Nguyen J, Amarasena T, Taiaroa G, Kinsella P, Liew KC, Tran T, Kent HE, Tan HX, Rowntree LC, Nguyen THO, Thomas PG, Kedzierska K, Petersen J, Rossjohn J, Williamson DA, Khoury D, Davenport MP, Kent SJ, Wheatley AK, Juno JA. Koutsakos M, et al. Among authors: amarasena t. Immunity. 2023 Apr 11;56(4):879-892.e4. doi: 10.1016/j.immuni.2023.02.017. Epub 2023 Feb 28. Immunity. 2023. PMID: 36958334 Free PMC article.
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain.
Wheatley AK, Pymm P, Esterbauer R, Dietrich MH, Lee WS, Drew D, Kelly HG, Chan LJ, Mordant FL, Black KA, Adair A, Tan HX, Juno JA, Wragg KM, Amarasena T, Lopez E, Selva KJ, Haycroft ER, Cooney JP, Venugopal H, Tan LL, O Neill MT, Allison CC, Cromer D, Davenport MP, Bowen RA, Chung AW, Pellegrini M, Liddament MT, Glukhova A, Subbarao K, Kent SJ, Tham WH. Wheatley AK, et al. Among authors: amarasena t. Cell Rep. 2021 Oct 12;37(2):109822. doi: 10.1016/j.celrep.2021.109822. Epub 2021 Sep 25. Cell Rep. 2021. PMID: 34610292 Free PMC article.
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory.
Wragg KM, Lee WS, Koutsakos M, Tan HX, Amarasena T, Reynaldi A, Gare G, Konstandopoulos P, Field KR, Esterbauer R, Kent HE, Davenport MP, Wheatley AK, Kent SJ, Juno JA. Wragg KM, et al. Among authors: amarasena t. Nat Immunol. 2022 May;23(5):768-780. doi: 10.1038/s41590-022-01175-5. Epub 2022 Mar 21. Nat Immunol. 2022. PMID: 35314848
Adaptive immunity to human coronaviruses is widespread but low in magnitude.
Tan HX, Lee WS, Wragg KM, Nelson C, Esterbauer R, Kelly HG, Amarasena T, Jones R, Starkey G, Wang BZ, Yoshino O, Tiang T, Grayson ML, Opdam H, D'Costa R, Vago A; Austin Liver Transplant Perfusionist Group; Mackay LK, Gordon CL, Wheatley AK, Kent SJ, Juno JA. Tan HX, et al. Among authors: amarasena t. Clin Transl Immunology. 2021 Mar 17;10(3):e1264. doi: 10.1002/cti2.1264. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33747512 Free PMC article.
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.
Parsons MS, Lloyd SB, Lee WS, Kristensen AB, Amarasena T, Center RJ, Keele BF, Lifson JD, LaBranche CC, Montefiori D, Wines BD, Hogarth PM, Swiderek KM, Venturi V, Davenport MP, Kent SJ. Parsons MS, et al. Among authors: amarasena t. Sci Transl Med. 2017 Aug 9;9(402):eaaf1483. doi: 10.1126/scitranslmed.aaf1483. Sci Transl Med. 2017. PMID: 28794282
28 results